The Januvia does so by inhibiting dipeptidyl-peptidase-4 (DPP-4), an enzyme that quickly metabolizes GLP-1.Regardless of which incretin mimetic is used, both types still produce higher levels of insulin by increasing GLP-1 receptor activity. Nearly 1,000 plaintiffs claim the drugs caused pancreatic cancer and pancreatitis. When you or a family member first learn about the possibility of a pancreatic cancer diagnosis, your life … The plaintiff’s doctor first prescribed Januvia in 2004. Not only did these patients, who suffered and in some cases died of cancer, have their cases thrown out, they were charged by Merck for legal fees.There have also been plenty of individual suits brought against Merck by people who suffered and believe that the company should have done more to warn them about the risks of using sitagliptin. If You or a Loved One Took Victoza, Saxenda, Byetta, Bydureon, Januvia, or Janumet and You Think That it May Have Caused Cancer, Contact Us to Learn More About a Possible Lawsuit. Pancreatitis can either be Several diabetes drugs have been linked to an increased risk of pancreatic cancer. I co-founded my own law firm, Treatment is needed right away to prevent this condition from being fatal.The FDA is also continuing to investigate the risks associated with sitagliptin, which also may include pancreatic cancer. Pancreatic cancer is a particularly troubling cancer as it rarely shows any signs or symptoms of its presence until the tumor has grown large enough to be a life-threatening concern. The federal court overseeing the nationwide Januvia and Victozia pancreatic cancer litigation appointed Mr. Kennerly to the “Plaintiffs’ Steering Committee,” the group of plaintiffs’ lawyers responsible for building the case against Merck, the manufacturer of Januvia and Janumet, and Novo Nordisk, the manufacturer of Victoza. All of these victims were taking Januvia and sometimes other type 2 diabetes drugs as well. Januvia diabetes drug linked to side effects pancreatitis, pancreatic cancer. Although the plaintiffs are appealing, a judge threw out the cases on the grounds that the FDA would never have let Merck put pancreatic cancer as a risk on Januvia’s label. The federal court overseeing the nationwide Januvia and Victozia pancreatic cancer litigation appointed Mr. Kennerly to the “Plaintiffs’ Steering Committee,” the group of plaintiffs’ lawyers responsible for building the case against Merck, the manufacturer of Januvia and Janumet, and Novo Nordisk, the manufacturer of Victoza. Januvia & Janumet Pancreatitis Lawsuits Our dangerous drug attorneys can help if you or someone you care about suffered as a result of taking Januvia or Janumet. Our attorneys are helping Januvia users or their loved ones file individual claims for their losses. If your claim is not successful for any reason, you do not owe us anything. The result of inhibiting it is an increase in insulin production, which regulates blood sugar, and a decrease in the amount of sugar released into the blood by the liver.Janumet attacks high blood sugar levels with two drugs. A list of open investigations and While Janumet contains metformin, which belongs to a separate class of drugs, it has also been linked to pancreatic cancer and there is no reason to believe that Janumet may be any safer than Januvia.In August 2013, the Januvia lawsuits were transferred to the U.S. District Court Southern District of California as part of a procedure known as It is believed that the way Januvia and other incretin mimetic drugs work to lower a diabetic’s blood sugar levels may cause pancreatitis (inflammation of the pancreas), which may lead to pancreatic cancer.Many diabetics suffer from high blood sugar levels because their bodies are resistant to the effects of insulin, a hormone that the pancreas produces to transport glucose (sugar) from the bloodstream to the body’s cells. I’m listed in Super Lawyers and Best Lawyers in America.The American Bar Association named this blog one of the Top 100 blogs written by lawyers in 2012, 2013, 2014, 2015, and 2016. Januvia, and the similar drug Janumet, were developed by Merck & Co. to treat type 2 diabetes. The study, published in the journal In 2011, the same group of researchers reviewed the FDA’s Adverse Event Reporting System for negative side effects reported by Januvia users and published their results in the journal Following its announcement, the FDA requested that Merck & Co. perform a follow-up study on the risk of pancreatitis in Januvia patients; however, New cases and investigations, settlement deadlines, and news straight to your inbox.ClassAction.org is a group of online professionals (designers, programmers and writers) with years of experience in the legal industry.We work closely with class action and mass tort attorneys across the country and help with investigations into corporate wrongdoing. When it is left untreated this type of diabetes can lead to serious complications that eventually become debilitating and life threatening. lawsuits can be viewed Hundreds have taken legal action against Merck & Co. alleging that the company’s type 2 diabetes drug Januvia puts patient at an increased risk of developing life-threatening pancreatic cancer. When you or a family member first learn about the possibility of a pancreatic cancer diagnosis, your life hits the “pause” button.